| 000 | 01700 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514181834.0 | ||
| 264 | 0 | _c20040907 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 024 | 7 |
_a10.1124/jpet.104.066191 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHill, Michael P | |
| 245 | 0 | 0 |
_aLevetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 2004 |
||
| 300 |
_a386-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmantadine _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCallithrix |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aDyskinesias _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aLevetiracetam |
| 650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
| 650 | 0 | 4 |
_aMPTP Poisoning _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiracetam _xanalogs & derivatives |
| 700 | 1 | _aRavenscroft, Paula | |
| 700 | 1 | _aBezard, Erwan | |
| 700 | 1 | _aCrossman, Alan R | |
| 700 | 1 | _aBrotchie, Jonathan M | |
| 700 | 1 | _aMichel, Anne | |
| 700 | 1 | _aGrimée, Renee | |
| 700 | 1 | _aKlitgaard, Henrik | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 310 _gno. 1 _gp. 386-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.104.066191 _zAvailable from publisher's website |
| 999 |
_c14724330 _d14724330 |
||